← Back to URGN

UroGen Pharma Ltd. - Ordinary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 06/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 06/05/2026Dec 2024Filed 10/03/2025Sep 2024Filed 06/11/2025Jun 2024Filed 07/08/2025
$72$51$27$24$20$25$25$22
−$14−$24−$33−$50−$44−$38−$24−$33
−$0.28−$0.47−$0.69−$1.05−$0.92−$0.80−$0.51−$0.82
5050484847474741

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.